Skip to main content
Top
Published in: Cough 1/2010

Open Access 01-12-2010 | Research

Objective cough frequency in Idiopathic Pulmonary Fibrosis

Authors: Angela L Key, Kimberley Holt, Andrew Hamilton, Jaclyn A Smith, John E Earis

Published in: Cough | Issue 1/2010

Login to get access

Abstract

Background

Cough is a common presenting symptom in patients with Idiopathic Pulmonary Fibrosis (IPF). This study measured cough rates in IPF patients and investigated the association between cough and measures of health related quality of life and subjective cough assessments. In addition, IPF cough rates were related to measures of physiological disease severity and compared to cough rates in health and other respiratory conditions.

Methods

Nineteen IPF patients, mean age 70.8 years ± 8.6, five female (26.3%) were studied. Subjects performed full pulmonary function testing, 24 hour ambulatory cough recordings, completed a cough related quality of life questionnaire (Leicester Cough Questionnaire) and subjectively scored cough severity with a visual analogue scale. Ambulatory cough recordings were manually counted and reported as number of coughs per hour.

Results

The 24hr cough rates were high (median 9.4, range 1.5-39.4), with day time rates much higher than night time (median 14.6, range 1.9-56.6 compared to 1.9, range 0-19.2, p = 0.003). Strong correlations were found between objective cough frequency and both the VAS (day r = 0.80, p < 0.001, night r = 0.71, p = 0.001) and LCQ (r = -0.80, p < 0.001), but not with measures of pulmonary function. Cough rates in IPF were higher than healthy subjects (p < 0.001) and asthma patients (p < 0.001) but similar to patients with chronic cough (p = 0.33).

Conclusions

This study confirms objectively that cough is a major, very distressing and disabling symptom in IPF patients. The strong correlations between objective cough counts and cough related quality of life measures suggest that in IPF patient's, perception of cough frequency is very accurate.
Appendix
Available only for authorised users
Literature
1.
go back to reference Coultas DB, Zumwalt RE, Black WC, Sobonya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994, 150: 967-972.CrossRefPubMed Coultas DB, Zumwalt RE, Black WC, Sobonya RE: The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994, 150: 967-972.CrossRefPubMed
2.
go back to reference Brown KK: Chronic Cough Due to Chronic Interstitial Pulmonary Diseases: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2006, 129: 180-185. 10.1378/chest.129.1_suppl.180S.CrossRef Brown KK: Chronic Cough Due to Chronic Interstitial Pulmonary Diseases: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2006, 129: 180-185. 10.1378/chest.129.1_suppl.180S.CrossRef
3.
go back to reference Swigris JJ, Stewart AL, Gould MK, Wilson SR: Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health and Quality of Life Outcomes. 2005, 3: 61-10.1186/1477-7525-3-61.PubMedCentralCrossRefPubMed Swigris JJ, Stewart AL, Gould MK, Wilson SR: Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health and Quality of Life Outcomes. 2005, 3: 61-10.1186/1477-7525-3-61.PubMedCentralCrossRefPubMed
4.
go back to reference Turner-Warwick M, Burrows B, Johnson A: Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980, 35: 171-180. 10.1136/thx.35.3.171.PubMedCentralCrossRefPubMed Turner-Warwick M, Burrows B, Johnson A: Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980, 35: 171-180. 10.1136/thx.35.3.171.PubMedCentralCrossRefPubMed
5.
go back to reference Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY: Idiopathic pulmonary fibrosis: clinical, histological, radiographic, physiological, scintigraphic, cytological and biochemical aspects. Ann Intern Med. 1976, 85: 769-788.CrossRefPubMed Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY: Idiopathic pulmonary fibrosis: clinical, histological, radiographic, physiological, scintigraphic, cytological and biochemical aspects. Ann Intern Med. 1976, 85: 769-788.CrossRefPubMed
6.
go back to reference Marsden PA, Smith JA, Kelsall AA, Owen E, Naylor JR, Webster D, Sumner H, Alam U, McGuinness K, Woodcock AA: A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol. 2008, 122 (5): 903-7. 10.1016/j.jaci.2008.08.029.CrossRefPubMed Marsden PA, Smith JA, Kelsall AA, Owen E, Naylor JR, Webster D, Sumner H, Alam U, McGuinness K, Woodcock AA: A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol. 2008, 122 (5): 903-7. 10.1016/j.jaci.2008.08.029.CrossRefPubMed
7.
go back to reference Kelsall A, Decalmer SC, McGuinness K, Woodcock A, Smith JA: Sex differences and predictors of objective cough frequency in chronic cough. Thorax. 2009, 64 (5): 393-398. 10.1136/thx.2008.106237.CrossRefPubMed Kelsall A, Decalmer SC, McGuinness K, Woodcock A, Smith JA: Sex differences and predictors of objective cough frequency in chronic cough. Thorax. 2009, 64 (5): 393-398. 10.1136/thx.2008.106237.CrossRefPubMed
8.
go back to reference Demedts M, Costabel U: ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J. 2002, 19 (5): 794-10.1183/09031936.02.00492002.CrossRefPubMed Demedts M, Costabel U: ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur Respir J. 2002, 19 (5): 794-10.1183/09031936.02.00492002.CrossRefPubMed
9.
go back to reference Campbell MJ, Machin D, SJ Walters: Medical Statistics - A textbook for health scientists. Wiley. 2007, 335-4 Campbell MJ, Machin D, SJ Walters: Medical Statistics - A textbook for health scientists. Wiley. 2007, 335-4
10.
go back to reference Smith J, Owen E, Earis J, Woodcock A: Cough in COPD: correlation of objective monitoring with cough challenge and subjective assessments. Chest. 2006, 130: 379-85. 10.1378/chest.130.2.379.PubMed Smith J, Owen E, Earis J, Woodcock A: Cough in COPD: correlation of objective monitoring with cough challenge and subjective assessments. Chest. 2006, 130: 379-85. 10.1378/chest.130.2.379.PubMed
11.
go back to reference Smith JA, Owen EC, Jones AM, Dodd ME, Webb AK, Woodcock A: Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax. 2006, 61: 425-9. 10.1136/thx.2005.050963.PubMedCentralCrossRefPubMed Smith JA, Owen EC, Jones AM, Dodd ME, Webb AK, Woodcock A: Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax. 2006, 61: 425-9. 10.1136/thx.2005.050963.PubMedCentralCrossRefPubMed
12.
go back to reference Smith J, Owen E, Earis J, Woodcock A: Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2006, 117: 8315-10.1016/j.jaci.2005.09.055.CrossRef Smith J, Owen E, Earis J, Woodcock A: Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2006, 117: 8315-10.1016/j.jaci.2005.09.055.CrossRef
13.
go back to reference Kelsall A, Decalmer S, Webster D, Brown N, Woodcock A, Smith J: How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J. 2008, 32: 175-179. 10.1183/09031936.00101307.CrossRefPubMed Kelsall A, Decalmer S, Webster D, Brown N, Woodcock A, Smith J: How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J. 2008, 32: 175-179. 10.1183/09031936.00101307.CrossRefPubMed
14.
go back to reference Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID: Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax. 2003, 58: 339-343. 10.1136/thorax.58.4.339.PubMedCentralCrossRefPubMed Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID: Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax. 2003, 58: 339-343. 10.1136/thorax.58.4.339.PubMedCentralCrossRefPubMed
15.
go back to reference Bland JM, Altman DG: "Statistical methods for assessing agreement between two methods of clinical measurement". Lancet. 1986, 1 (8476): 307-10.CrossRefPubMed Bland JM, Altman DG: "Statistical methods for assessing agreement between two methods of clinical measurement". Lancet. 1986, 1 (8476): 307-10.CrossRefPubMed
16.
go back to reference Krishnan V, McCormack MC, Mathai SC, Agarwal S, Richardson B, Horton MR, Polito AJ, Collop NA, Danoff SK: Sleep quality and health related quality of life in idiopathic pulmonary fibrosis. Chest. 2008, 134 (4): 693-8. 10.1378/chest.08-0173. Epub 2008 Jul 14CrossRefPubMed Krishnan V, McCormack MC, Mathai SC, Agarwal S, Richardson B, Horton MR, Polito AJ, Collop NA, Danoff SK: Sleep quality and health related quality of life in idiopathic pulmonary fibrosis. Chest. 2008, 134 (4): 693-8. 10.1378/chest.08-0173. Epub 2008 Jul 14CrossRefPubMed
17.
go back to reference Doherty MJ, Mister R, Pearson MG, Calverley PM: Capsaicin induced cough in cryptogenic fibrosing alveolitis. Thorax. 2000, 55: 1028-1032. 10.1136/thorax.55.12.1028.PubMedCentralCrossRefPubMed Doherty MJ, Mister R, Pearson MG, Calverley PM: Capsaicin induced cough in cryptogenic fibrosing alveolitis. Thorax. 2000, 55: 1028-1032. 10.1136/thorax.55.12.1028.PubMedCentralCrossRefPubMed
18.
go back to reference Hope-Gill BD, Hilldrup S, Davies C, Newton RP, Harrison NK: A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003, 168: 995-1002. 10.1164/rccm.200304-597OC.CrossRefPubMed Hope-Gill BD, Hilldrup S, Davies C, Newton RP, Harrison NK: A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003, 168: 995-1002. 10.1164/rccm.200304-597OC.CrossRefPubMed
19.
go back to reference Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE, Pellegrini CA: High prevalence of abnormal acid gastrooesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006, 27 (1): 136-42. 10.1183/09031936.06.00037005.CrossRefPubMed Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE, Pellegrini CA: High prevalence of abnormal acid gastrooesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006, 27 (1): 136-42. 10.1183/09031936.06.00037005.CrossRefPubMed
20.
go back to reference Madison JM, Irwin RS: Chronic cough in adults with interstitial lung disease. Curr Opin Pulm Med. 2005, 11 (5): 412-6. 10.1097/01.mcp.0000174249.07762.37.CrossRefPubMed Madison JM, Irwin RS: Chronic cough in adults with interstitial lung disease. Curr Opin Pulm Med. 2005, 11 (5): 412-6. 10.1097/01.mcp.0000174249.07762.37.CrossRefPubMed
21.
go back to reference N Kim Harrison: Idiopathic pulmonary fibrosis: a nervous cough?. Pulm Pharmacol & Ther. 2004, 17: 347-350.CrossRef N Kim Harrison: Idiopathic pulmonary fibrosis: a nervous cough?. Pulm Pharmacol & Ther. 2004, 17: 347-350.CrossRef
Metadata
Title
Objective cough frequency in Idiopathic Pulmonary Fibrosis
Authors
Angela L Key
Kimberley Holt
Andrew Hamilton
Jaclyn A Smith
John E Earis
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cough / Issue 1/2010
Electronic ISSN: 1745-9974
DOI
https://doi.org/10.1186/1745-9974-6-4

Other articles of this Issue 1/2010

Cough 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.